Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Abgenix raises $453.6 million

ABGX topped the charts with the largest biotech follow-on since 1994, raising $453.6

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE